Table 1.
Cell lines | Reagent | Treatment period (hr) |
|||
---|---|---|---|---|---|
24 | 48 | 72 | 96 | ||
Cal-27 | |||||
MEa | 36.3 ± 2.6 | 25.7 ± 2.3 | 14.2 ± 2.5 | 8.2 ± 1.9 | |
MGN | 20.7 ± 1.8* | 11.9 ± 0.6* | 5.1 ± 0.6* | 4.0 ± 0.8* | |
HNK | 20.8 ± 1.3* | 12.2 ± 1.0* | 6.6 ± 0.6* | 4.2 ± 0.4* | |
MHNK | 14.5 ± 0.9* | 7.7 ± 0.8* | 5.6 ± 1.4* | 3.2 ± 0.3* | |
Fraction 1 | >100* | ||||
Fraction 2 | 72.1 ± 2.3* | ||||
Fraction 3 | 61.8 ± 9.4* | ||||
Fraction Ab | 22.5 ± 1.4 | ||||
1:1:1 (MGN:HNK:MHNK) | 4.8 ± 0.2* | ||||
1:2:6 (MGN:HNK:MHNK) | 3.8 ± 0.2* | ||||
1:2:3 (MGN:HNK:MHNK) | 3.9 ± 0.3* | ||||
5-FU (positive control) | 0.4 ± 0.1* | ||||
SCC-9 | |||||
MEa | 14.4 ± 2.9 | ||||
MGN | 7.9 ± 0.4* | ||||
HNK | 5.5 ± 0.6* | ||||
MHNK | 5.2 ± 1.3* | ||||
Fraction 1 | > 100* | ||||
Fraction 2 | > 100* | ||||
Fraction 3 | 99.5 ± 0.6* | ||||
Fraction Ab | 19.6 ± 1.7 | ||||
5-FU (positive control) | 1.9 ± 0.4* |
Ratio of three key active ingredients in ME was 1.0 : 1.4 : 1.2 (MGN : HNK : MHNK)
Ratio of compounds in Fraction A was 1.0 : 0.82 : 0.28 (MGN : HNK : MHNK)
indicates significant different with the respective the respective IC50 value of ME. (p < 0.05). Statistical analysis was performed using one-way ANOVA with Tukey similarity test.